Orphenadrine Citrate NDC 43386-480

Product information

Brand name (proprietary)

Orphenadrine Citrate

Generic name (nonproprietary)

orphenadrine citrate

Active ingredients

Orphenadrine citrate — 100 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Lupin Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 040284

Marketing start

Jun 19, 1998

Listing expires

Dec 31, 2026

Other FDA classes

Centrally-mediated Muscle Relaxation (Physiologic effect)

Identifiers

Product ID 43386-480_e80ecc89-bd45-4796-850b-c379a79ac7abSPL ID e80ecc89-bd45-4796-850b-c379a79ac7abSPL set ID 7b76c8a7-dd0c-481c-8299-26dfd38ce066RxCUI 994521UNII X0A40N8I4S

Pharmacologic class

Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443386048024 followed by a unit qualifier and the quantity Copy

Package 43386-0480-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 040284

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.